High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer

Cancer

Volumn 116, Issue 10, 2010, Pages 2476-2485

  Iwata, Hiromitsu ^a,b   Murakami, Masao ^b   Demizu, Yusuke ^b   Miyawaki, Daisuke ^b,c   Terashima, Kazuki ^b   Niwa, Yasue ^b   Mima, Masayuki ^b   Akagi, Takashi ^b   Hishikawa, Yoshio ^b   Shibamoto, Yuta ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b HYOGO ION BEAM MEDICAL CENTER   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carbon ion therapy; Hypofractionated high dose irradiation; Nonsmall cell lung cancer; Proton therapy; Stage I

Indexed keywords

FLUORODEOXYGLUCOSE F 18; CARBON; ION; PROTON;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; ION THERAPY; LINEAR ACCELERATOR; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; SYNCHROTRON; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TREATMENT PLANNING; CLINICAL TRIAL; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; RADIOTHERAPY;

AGED; AGED, 80 AND OVER; CARBON; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IONS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTONS; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 77952577061     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24998     Document Type: Article

References (38)

1. Asamura H, Goya T, Koshiishi Y, et al. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol. 2008;3:46-52.
2. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol.2007;2:S94-S100.
3. Takeda A, Sanuki N, Kunieda E, et al. Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in 5 fractions to the periphery of the planning target volume calculated using a superposition algorithm. Int J Radiat Oncol Biol Phys. 2009;73:442-448.
4. Haasbeek CJ, Lagerwaard FJ, de Jaeger K, Slotman BJ, Senan S. Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy. Cancer. 2009;115:587-594.
5. Hof H, Muenter M, Oetzel D, Hoess A, Debus J, Herfarth K. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer. 2007;110:148-155. (Pubitemid 46986427)
6. Zimmermann FB, Bamberg M, Molls M, Jeremic B. Radiation therapy alone in early stage non-small cell lung cancer. Semin Surg Oncol. 2003;21:91-97. (Pubitemid 37237418)
7. Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiotherapy for stage I non-small-cell lung cancer. Lung Cancer. 2005;48:107-114. (Pubitemid 40381006)
8. Suit H, Goldberg S, Niemierko A, et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncol. 2003;42:800-808.
9. Lee CH, Tait D, Nahum AE, Webb S. Comparison of proton therapy and conformal X-ray therapy in non-small cell lung cancer (NSCLC). Br J Radiol. 1999;72:1078-1084.
10. Ando K, Koike S, Uzawa A, et al. Biological gain of carbon-ion radiotherapy for the early response of tumor growth delay and against early response of skin reaction in mice. J Radiat Res. 2005;46:51-57.
11. Hishikawa Y, Oda Y, Mayahara H, et al. Status of the clinical work at Hyogo. Radiother Oncol.2004;73:S38-S40.
12. Mayahara H, Oda Y, Kawaguchi A, et al. A case of hepatocellular carcinoma initially treated by carbon ions, followed by protons for marginal recurrence with portal thrombus. Radiat Med. 2005;23:513-519.
13. Mayahara H, Murakami M, Kagawa K, et al. Acute morbidity of proton therapy for prostate cancer: the Hyogo Ion Beam Medical Center experience. Int J Radiat Oncol Biol Phys. 2007;69:434-443.
14. Demizu Y, Murakami M, Miyawaki D, et al. Analysis of vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves. Int J Radiat Oncol Biol Phys. 2009;75:1487-1492.
15. Nihei K, Ogino T, Ishikura S, Nishimura H. High-dose proton beam therapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006;65:107-111.
16. Hata M, Tokuuye K, Kagei K, et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Int J Radiat Oncol Biol Phys. 2007;68:786-793.
17. Miyamoto T, Baba M, Sugane T, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of 4 fractions during 1 week. J Thorac Oncol. 2007;2:916-926. (Pubitemid 47511595)
18. Minohara S, Kanai T, Endo M, Noda K, Kanazawa M. Respiratory gated irradiation system for heavy-ion radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:1097-1103. (Pubitemid 30345611)
19. Kagawa K, Murakami M, Hishikawa Y, et al. Preclinical biological assessment of proton and carbon ion beams at Hyogo Ion Beam Medical Center. Int J Radiat Oncol Biol Phys. 2002;54:928-938.
20. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47:207-214.
21. Georg D, Hillbrand M, Stock M, Dieckmann K, Potter R. Can protons improve SBRT for lung lesions? Dosimetric considerations. Radiother Oncol. 2008;88:368-375.
22. Engelsman M, Kooy HM. Target volume dose considerations in proton beam treatment planning for lung tumors. Med Phys. 2005;32:3549-3557.
23. Arvidson NB, Mehta MP, Tome WA. Dose coverage beyond the gross tumor volume for various stereotactic body radiotherapy planning techniques reporting similar control rates for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;72:1597-1603.
24. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63:1427-1431.
25. Kanai T, Matsufuji N, Miyamoto T, et al. Examination of GyE system for HIMAC carbon therapy. Int J Radiat Oncol Biol Phys. 2006;64:650-656. (Pubitemid 43083456)
26. Koike S, Ando K, Uzawa A, et al. Significance of fractionated irradiation for the biological therapeutic gain of carbon ions. Radiat Prot Dosimetry. 2002;99:405-408.
27. Kraft G. The radiobiological and physical basis for radiotherapy with protons and heavier ions. Strahlenther Onkol. 1990;166:10-13. (Pubitemid 20086295)
28. Shibamoto Y, Ike O, Mizuno H, Fukuse T, Hitomi S, Takahashi M. Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome. Clin Cancer Res. 1998;4:677-682.
29. Mizoe JE, Tsujii H, Kamada T, et al. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;60:358-364.
30. Murakami M, Demizu Y, Niwa Y, et al. Current Status of the HIBMC, Providing Particle Beam Radiation Therapy for More Than 2,600 Patients, and the Prospects of Laser-Driven Proton Radiotherapy. In: Dössel O, Schlegel WC, eds. WC 2009, IFMBE Proceedings, vol. 25. Berlin: Springer Berlin Heidelberg, 2009:878-882.
31. Iwata H, Shibamoto Y, Murata R, et al. Estimation of errors associated with the use of the linear-quadratic formalism for evaluation of biological equivalence between single and hypofractionated radiation doses: an in vitro study. Int J Radiat Oncol Biol Phys. 2009;75:482-488.
32. Miyamoto T, Baba M, Yamamoto N, et al. Curative treatment of stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys. 2007;67:750-758. (Pubitemid 46215886)
33. Bush DA, Slater JD, Shin BB, Cheek G, Miller DW, Slater JM. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest. 2004;126:1198-1203. (Pubitemid 39391251)
34. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol. 2009;27:3290-3296.
35. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833-4839.
36. Milano MT, Constine LS, Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol.2008;3:36.
37. Kanematsu N, Akagi T, Takatani Y, Yonai S, Sakamoto H, Yamashita H. Extended collimator model for pencil-beam dose calculation in proton radiotherapy. Phys Med Biol. 2006;51:4807-4817. (Pubitemid 44429845)
38. Kanematsu N, Yonai S, Ishizaki A, Torikoshi M. Computational modeling of beam-customization devices for heavy-charged-particle radiotherapy. Phys Med Biol. 2008;53:3113-3127. (Pubitemid 351892390)